Navigating the Foreign Corrupt Practices Act for the Life Science Industry
10 December 2015
Past Event
Location
Web Conference
Partner David Simon will discuss the Foreign Corrupt Practices Act and its effect on the life sciences industry.
The webinar provides an in-depth overview of the significant risks involved when companies lack the management of compliance.
To watch a recording of the webinar, click here.
To watch a recording of the webinar, click here.
Related Services
Industry Teams
Practice Areas
Insights
Do You Know What IMMEX Stands For?
16 July 2019
Dashboard Insights
Does The U.S. Need STRONGER Patents?
16 July 2019
PTAB Trial Insights
California Establishes Fund to Combat Wildfire Threats
15 July 2019
Renewable Energy Outlook
There’s No Place Like Home – But Is That a Reasonable Accommodation?
15 July 2019
Labor & Employment Law Perspectives
Vogel Discusses Pros, Cons of Crypto-Enabled Charitable Donations
15 July 2019
Legaltech News
Morabito Honored as Top U.S.A. Women Dealmaker
12 July 2019
Overly Quoted on Importance of Asset Tracking
11 July 2019
Security Magazine
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
2019 NDI Executive Exchange
14-15 November 2019
Chicago, IL
MAGI’s Clinical Research Conference
29 October 2019
Las Vegas, NV
Association for Corporate Counsel Annual Meeting 2019
27-30 October 2019
Phoenix, AZ
Navigating the Foreign Corrupt Practices Act for the Life Science Industry
Location
Web Conference